Alterations and role of human cathepsin D in cancer metastasis

被引:45
|
作者
Rochefort, H
Liaudet, E
Garcia, M
机构
[1] Inst. Natl. Sante Recherche Medicale, Unit 148, University of Montpellier I, F-33090 Montpellier
关键词
metastasis; breast cancer; proteases; cathepsin D; phagocytosis; growth factor; growth inhibitor; extracellular matrix; bFGF;
D O I
10.1159/000468620
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cathepsin D (Cath D) overexpression in breast cancer cells is associated with increased risk of metastasis in patients according to several clinical studies. The amino acid sequence of Cath D in two breast cancer cell lines was normal, but glycosylation appears to be different with more acidic isoforms. Transfection of a human cDNA Cath D expression vector increases the metastatic potential of 3Y1-Ad12 embryonic rat tumorigenic cells when intravenously injected into nude mide. The mechanism of Cath-D-induced metastasis seems to require maturation of the proenzyme, mostly in large acidic compartments identified as phagosomes. Cath D is mitogenic in different cell types, and different substrates (growth inhibitors, precursors of growth factors, etc.) are proposed to mediate this activity.
引用
收藏
页码:106 / 116
页数:11
相关论文
共 50 条
  • [1] Cathepsin D in cancer metastasis: A protease and a ligand
    Rochefort, H
    Liaudet-Coopman, E
    APMIS, 1999, 107 (01) : 86 - 95
  • [2] Biological and clinical significance of cathepsin D in breast cancer metastasis
    Garcia, M
    Platet, N
    Liaudet, E
    Laurent, V
    Derocq, D
    Brouillet, JP
    Rochefort, H
    STEM CELLS, 1996, 14 (06) : 642 - 650
  • [3] The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer
    Pranjol, Md Zahidul Islam
    Gutowski, Nicholas
    Hannemann, Michael
    Whatmore, Jacqueline
    BIOMOLECULES, 2015, 5 (04) : 3260 - 3279
  • [4] Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview
    Rochefort, H
    Garcia, M
    Glondu, M
    Laurent, V
    Liaudet, E
    Rey, JM
    Roger, P
    CLINICA CHIMICA ACTA, 2000, 291 (02) : 157 - 170
  • [5] Expression of Cathepsin-D in Primary Breast Cancer and Corresponding Local Recurrence or Metastasis: An Immunohistochemical Study
    Dian, D.
    Vrekoussis, T.
    Shabani, N.
    Mylonas, I.
    Kuhn, C.
    Schindlbeck, C.
    Navrozoglou, I.
    Friese, K.
    Makrigiannakis, A.
    Jeschke, U.
    ANTICANCER RESEARCH, 2012, 32 (03) : 901 - 905
  • [6] Cathepsin D messenger RNA is downregulated in human lung cancer
    Shubin, Andrey V.
    Demidyuk, Ilya V.
    Kurinov, Alexander M.
    Demkin, Vladimir V.
    Vinogradova, Tatyana V.
    Zinovyeva, Marina V.
    Sass, Alexander V.
    Zborovskaya, Irina B.
    Kostrov, Sergey V.
    BIOMARKERS, 2010, 15 (07) : 608 - 613
  • [7] c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
    Knopfova, Lucia
    Benes, Petr
    Pekarcikova, Lucie
    Hermanova, Marketa
    Masarik, Michal
    Pernicova, Zuzana
    Soucek, Karel
    Smarda, Jan
    MOLECULAR CANCER, 2012, 11
  • [8] c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
    Lucia Knopfová
    Petr Beneš
    Lucie Pekarčíková
    Markéta Hermanová
    Michal Masařík
    Zuzana Pernicová
    Karel Souček
    Jan Šmarda
    Molecular Cancer, 11
  • [9] Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells
    Murielle Glondu
    Emmanuelle Liaudet-Coopman
    Danielle Derocq
    Nadine Platet
    Henri Rochefort
    Marcel Garcia
    Oncogene, 2002, 21 : 5127 - 5134
  • [10] Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells
    Glondu, M
    Liaudet-Coopman, E
    Derocq, D
    Platet, N
    Rochefort, H
    Garcia, M
    ONCOGENE, 2002, 21 (33) : 5127 - 5134